Research ArticleHEALTH AND MEDICINE

Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma

See allHide authors and affiliations

Science Advances  10 Jun 2020:
Vol. 6, no. 24, eaay7973
DOI: 10.1126/sciadv.aay7973
PDF Container

Stay Connected to Science Advances

Navigate This Article